What Corporate Venture Funds Get Wrong about Strategic Value
Corporate venture funds often chase financial returns while ignoring strategic value. Here’s what it takes to turn healthcare portfolio investments into lasting business impact.
5 takeaways from ViVE 2022: Day 1
Healthcare executives and investors shared insights on a wide range of topics from partnering with startups, real world evidence, health equity and new developments in the regulation of patient data.
presented by
The Healthcare Payments Industry Faces a Perception Challenge
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Biotech investment timelines: Then and Now
The timelines for biotech investment is getting shaken up, as new funding models enter the fray. These infographs lay out the change quite nicely.